5-methoxypentanoyl chloride | 96720-53-5

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 酰卤
• 英文名称: 5-methoxypentanoyl chloride
• 英文别名: 5-methoxy-valeryl chloride；5-methoxyvaleric chloride
• CAS: 96720-53-5
• 化学式: C₆H₁₁ClO₂
• 分子量: 150.605
• InChiKey: RROZEWMGPANRBO-UHFFFAOYSA-N

物化性质

• 沸点：
  174.5±23.0 °C(Predicted)
• 密度：
  1.057±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-methoxypentanoyl chloride 、 (E)-1-(phenyldimethylsilyl)-2-buten-1-ol 以 吡啶 、 苯 为溶剂， 反应 6.0h， 以87%的产率得到5-Methoxy-pentanoic acid (E)-1-(dimethyl-phenyl-silanyl)-but-2-enyl ester
  参考文献：
  名称：

  乙烯基硅烷介导的多烯环化。二氢compactin的八氢萘部分的合成。

  摘要：

  描述了HMG-CoA还原酶抑制剂二氢compactin（1）的八氢萘部分12的合成，其中乙烯基硅烷封端的多烯环化和克莱森重排的变体提供了区域和立体控制的关键要素。

  DOI：

  10.1016/s0040-4039(00)98414-4
• 作为产物：
  描述：

  5-甲氧基戊酸 在 氯化亚砜 作用下， 生成 5-methoxypentanoyl chloride
  参考文献：
  名称：

  Leimu, Chemische Berichte, 1937, vol. 70, p. 1042

  摘要：

  DOI：

文献信息

• Dihydropyridines and new uses thereof
  申请人：Synaptic Pharmaceutical Corporation

  公开号：US05767131A1

  公开（公告）日：1998-06-16

  The invention provides a method of treating benign prostatic hyperplasia in a subject which comprises administering to the subject a therapeutically effective amount of a compound having the structure: ##STR1## wherein Y is --(CH.sub.2).sub.n --, where n is 1, 2, 3, 4 or 5; --(CH.sub.2).sub.h --O--(CH.sub.2).sub.k --, where h and k are independently the same or different and are 2, 3 or 4; --(CH.sub.2).sub.h --CH.dbd.CH--(CH.sub.2).sub.k --; or --(CH.sub.2).sub.h --C.tbd.C--(CH.sub.2).sub.k --, where h and k are independently the same or different and are 1, 2, 3 or 4; wherein Z is O, NH, or CH.sub.2 ; wherein R.sup.1 is a linear or branched chain alkyl, alkoxyalkyl or arylalkyl group; wherein R.sup.2 and R.sup.4 are independently the same or different and are H, or a linear or branched chain alkyl group; wherein R.sup.3 is H, a linear or branched chain alkyl, alkoxy, alkoxyalkyl or acyl group; and wherein R.sup.5 and R.sup.6 are independently the same or different and are H, OH, Cl, Br, F, NO.sub.2, CN, CF.sub.3, or NH.sub.2, or a linear or branched chain alkyl, alkoxy, alkoxycarbonyl, acyl, alkylsulfoxide, alkylsulfone, or mono- or dialkylamino group. Other active compounds containing one, two or three rings are also disclosed as well as pharmaceutical compositions prepared therefrom and methods of use in the treatment of BPH, inhibition of cholesterol synthesis, and reduction of intraocular pressure.

  该发明提供了一种治疗良性前列腺增生的方法，包括向受试者施用具有以下结构的化合物的治疗有效量： 其中Y为--(CH.sub.2).sub.n --，其中n为1、2、3、4或5；--(CH.sub.2).sub.h --O--(CH.sub.2).sub.k --，其中h和k独立且相同或不同，为2、3或4；--(CH.sub.2).sub.h --CH.dbd.CH--(CH.sub.2).sub.k --；或--(CH.sub.2).sub.h --C.tbd.C--(CH.sub.2).sub.k --，其中h和k独立且相同或不同，为1、2、3或4；其中Z为O、NH或CH.sub.2；其中R.sup.1为线性或支链烷基、烷氧基烷基或芳基烷基；其中R.sup.2和R.sup.4独立且相同或不同，为H，或线性或支链烷基；其中R.sup.3为H、线性或支链烷基、烷氧基、烷氧基烷基或酰基；其中R.sup.5和R.sup.6独立且相同或不同，为H、OH、Cl、Br、F、NO.sub.2、CN、CF.sub.3或NH.sub.2，或线性或支链烷基、烷氧基、烷氧羰基、酰基、烷基亚砜、烷基砜、或单烷基或二烷基氨基基团。还公开了含有一、两个或三个环的其他活性化合物，以及由此制备的药物组合物和在治疗BPH、抑制胆固醇合成和降低眼压中的使用方法。
• Method for producing axial asymmetric compounds, intermediates for producing the same, complexes of transition metals with novel axial asymmetric compounds as the ligands, catalysts for asymmetric hydrogenation, and catalysts for forming asymmetric carbon-carbon bonds
  申请人：Takasago International Corporation

  公开号：US20010047110A1

  公开（公告）日：2001-11-29

  The invention provides a metal complex comprising a ligand and a metal. The ligand is an aminophosphine compound represented by the following formula (1) 1 [Each Ar represents an aryl group optionally substituted with a halogen atom, a lower alkyl group having 1 to 4 carbon atom or an alkoxy group, both Ar's being same or different with each other. R 1 and R 2 represent hydrogen atom, a cycloalkyl group having 5 to 7 carbon atoms, or an alkyl group having 1 to 6 carbon atom optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, with R 1 and R 2 being same or different with each other. Alternatively, one of R 1 and R 2 is hydrogen atom and the other is —COR 3 (R 3 represents a cycloalkyl group having 5 to 7 carbon atoms, a lower alkyl group having 1 to 6 carbon atom optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, a substituted or unsubstituted phenyl group, or a lower alkoxy group having 1 to 6 carbon atom optionally substituted with a cycloalkyl group having 5 to 7 carbon atoms, a halogen atom, a lower alkoxy group or phenyl group) or —SO 2 R 4 (R 4 represents a cycloalkyl group having 5 to 7 carbon atoms, an alkyl group optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, or substituted or unsubstituted phenyl group). n represents 0]. The metal is rhodium, ruthenium, iridium or nickel.

  本发明提供了一种包含配体和金属的金属配合物。该配体是由以下式子（1）表示的氨基膦化合物组成：1[每个Ar代表一个芳基基团，可以选择地用卤原子、具有1到4个碳原子的较低烷基基团或烷氧基取代，两个Ar相同或不同。R1和R2代表氢原子，具有5到7个碳原子的环烷基团或具有1到6个碳原子的烷基基团，可以选择地用卤原子、较低烷氧基或苯基取代，其中R1和R2相同或不同。或者，R1和R2中的一个是氢原子，另一个是-COR3（R3代表具有5到7个碳原子的环烷基团、具有1到6个碳原子的较低烷基基团，可以选择地用卤原子、较低烷氧基或苯基取代，取代或未取代的苯基或具有5到7个碳原子的环烷基团、卤原子、较低烷氧基或苯基取代的具有1到6个碳原子的较低烷氧基）或-SO2R4（R4代表具有5到7个碳原子的环烷基团、可以选择地用卤原子、较低烷氧基或苯基取代的烷基，或取代或未取代的苯基）。n代表0。金属是铑、钌、铱或镍。
• Aminophosphine-metal complex for asymmetric reactions
  申请人：Takasago International Corporation

  公开号：EP1013658A1

  公开（公告）日：2000-06-28

  The invention provides a metal complex comprising a ligand and a metal. The ligand is an aminophosphine compound represented by the following formula (1) [Each Ar represents an aryl group optionally substituted with a halogen atom, a lower alkyl group having 1 to 4 carbon atom or an alkoxy group, both Ar's being same or different with each other. R1 and R2 represent hydrogen atom, a cycloalkyl group having 5 to 7 carbon atoms, or an alkyl group having 1 to 6 carbon atom optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, with R1 and R2 being same or different with each other. Alternatively, one of R1 and R2 is hydrogen atom and the other is -COR3 (R3 represents a cycloalkyl group having 5 to 7 carbon atoms, a lower alkyl group having 1 to 6 carbon atom optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, a substituted or unsubstituted phenyl group, or a lower alkoxy group having 1 to 6 carbon atom optionally substituted with a cycloalkyl group having 5 to 7 carbon atoms, a halogen atom, a lower alkoxy group or phenyl group) or -SO2R4 (R4 represents a cycloalkyl group having 5 to 7 carbon atoms, an alkyl group optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, or substituted or unsubstituted phenyl group). n represents 0]. The metal is rhodium, ruthenium, iridium or nickel.

  本发明提供了一种由配体和金属组成的金属配合物。配体是由下式（1）表示的氨基膦化合物 [每个 Ar 代表一个芳基，可任选被一个卤素原子、一个具有 1 至 4 个碳原子的低级烷基或一个烷氧基取代，两个 Ar 彼此相同或不同。R1 和 R2 代表氢原子、具有 5 至 7 个碳原子的环烷基或具有 1 至 6 个碳原子的烷基，可选择被卤素原子、低级烷氧基或苯基取代，R1 和 R2 彼此相同或不同。或者，R1 和 R2 中的一个是氢原子，另一个是-COR3（R3 代表具有 5 至 7 个碳原子的环烷基、具有 1 至 6 个碳原子且任选被卤素原子取代的低级烷基、低级烷氧基或苯基、取代或未取代的苯基、或具有 1 至 6 个碳原子的低级烷氧基，可选择被具有 5 至 7 个碳原子的环烷基、卤素原子、低级烷氧基或苯基取代）或 -SO2R4 （R4 代表具有 5 至 7 个碳原子的环烷基、可选择被卤素原子取代的烷基、低级烷氧基或苯基、取代或未取代的苯基）。n 代表 0]。金属是铑、钌、铱或镍。
• Method for preparing aminophosphines and aminophosphine oxides, intermediates therefor
  申请人：Takasago International Corporation

  公开号：EP1469004A1

  公开（公告）日：2004-10-20

  The invention provides a metal complex comprising a ligand and a metal. The ligand is an aminophosphine compound represented by the following formula (1) [Each Ar represents an aryl group optionally substituted with a halogen atom, a lower alkyl group having 1 to 4 carbon atom or an alkoxy group, both Ar's being same or different with each other. R1 and R2 represent hydrogen atom, a cycloalkyl group having 5 to 7 carbon atoms, or an alkyl group having 1 to 6 carbon atom optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, with R1 and R2 being same or different with each other. Alternatively, one of R1 and R2 is hydrogen atom and the other is -COR3 (R3 represents a cycloalkyl group having 5 to 7 carbon atoms, a lower alkyl group having 1 to 6 carbon atom optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, a substituted or unsubstituted phenyl group, or a lower alkoxy group having 1 to 6 carbon atom optionally substituted with a cycloalkyl group having 5 to 7 carbon atoms, a halogen atom, a lower alkoxy group or phenyl group) or -SO2R4 (R4 represents a cycloalkyl group having 5 to 7 carbon atoms, an alkyl group optionally substituted with a halogen atom, a lower alkoxy group or phenyl group, or substituted or unsubstituted phenyl group). n represents 0]. The metal is rhodium, ruthenium, iridium or nickel.

  本发明提供了一种由配体和金属组成的金属配合物。配体是由下式（1）表示的氨基膦化合物 [每个 Ar 代表一个芳基，可任选被一个卤素原子、一个具有 1 至 4 个碳原子的低级烷基或一个烷氧基取代，两个 Ar 彼此相同或不同。R1 和 R2 代表氢原子、具有 5 至 7 个碳原子的环烷基或具有 1 至 6 个碳原子的烷基，可选择被卤素原子、低级烷氧基或苯基取代，R1 和 R2 彼此相同或不同。或者，R1 和 R2 中的一个是氢原子，另一个是-COR3（R3 代表具有 5 至 7 个碳原子的环烷基、具有 1 至 6 个碳原子且任选被卤素原子取代的低级烷基、低级烷氧基或苯基、取代或未取代的苯基、或具有 1 至 6 个碳原子的低级烷氧基，可选择被具有 5 至 7 个碳原子的环烷基、卤素原子、低级烷氧基或苯基取代）或 -SO2R4 （R4 代表具有 5 至 7 个碳原子的环烷基、可选择被卤素原子取代的烷基、低级烷氧基或苯基、取代或未取代的苯基）。n 代表 0]。金属是铑、钌、铱或镍。
• US5767131A
  申请人：——

  公开号：US5767131A

  公开（公告）日：1998-06-16